Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Anecdotal use of mTOR inhibition as primary prevention was reported for patients with kidney transplants.
“For patients with kidney transplants, anecdotal use of mTOR inhibition (mTORi) as primary prevention was reported12,13.”
From Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation (2019) · cites this paper as [12]
The citation lists haven’t been fetched yet
References 4 · Cited by 23
- Authors
- Sadaat, M., & Jang, S.
- Affiliations
- Inova Fairfax Hospital (US)
- Venue
- Journal of Oncology Practice
- Published
- 2018-03
- Volume
- 14
- Issue
- 3
- Pages
- 198-199
- ISSN
- 1554-7477 (ISSN-L)
- 1935-469X
- OpenAlex
- W2781189224
- Cited by
- 23
- References
- 4
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 1
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Oncology Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal cell carcinoma treatment
- Keywords
- pembrolizumab, renal allograft, allograft preservation, tumor response, immunosuppressive therapy, immune checkpoint inhibitors, kidney transplantation, cancer immunotherapy
- MeSH terms
- Antineoplastic Agents, Immunological, Graft Survival, Humans, Immunosuppressive Agents, Male, Middle Aged, Prednisone, Skin Neoplasms, Kidney Transplantation, Treatment Outcome, Sirolimus, Antibodies, Monoclonal, Humanized, Allografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
